accountthe European Union immediately. The device replaces the older Promus stent, which is Boston Scientific's version of Abbott Laboratories' Xience stent. Boston Scientific pays a 40 percent royalty to Abbott on all sales of the stents. Stents are mesh metal...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to New Boston Scientific stent approved in Europe
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
